| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/16/2003 | WO2002053712A3 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 01/16/2003 | WO2002052038A3 Method for normalizing the relative intensities of detection signals in hybridization arrays |
| 01/16/2003 | WO2002049761A3 Automated laboratory system and method |
| 01/16/2003 | WO2002048672A3 Reagents and methods for use inn the detection of analytes |
| 01/16/2003 | WO2002047071A3 Multiple data layer optical discs for detecting analytes |
| 01/16/2003 | WO2002046769A3 A monoclonal antibody-based diagnostic assay for gamma fibrinogen |
| 01/16/2003 | WO2002046761A3 Methods for detecting analytes using optical discs and optical disc readers |
| 01/16/2003 | WO2002046752A3 Optical determination of glucose utilizing boronic acid adducts |
| 01/16/2003 | WO2002044327A3 Method and apparatus for protein manipulation |
| 01/16/2003 | WO2002042416A3 Immunoassay for fish identification |
| 01/16/2003 | WO2002040540A3 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 01/16/2003 | WO2002037119A3 Method of diagnosing a transmissible spongiform encephalopathy |
| 01/16/2003 | WO2002034769A3 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 01/16/2003 | WO2002033044A3 Methods of high-throughput screening for internalizing antibodies |
| 01/16/2003 | WO2002032286A3 Protein-protein interactions in neurodegenerative diseases |
| 01/16/2003 | WO2002031144A3 Identification of cytotoxic activity from the ink of aplysia punctata |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002030944A3 Fluorescent nucleobase conjugates having anionic linkers |
| 01/16/2003 | WO2002030266A3 Detection of dna damage |
| 01/16/2003 | WO2002029416A3 Method for determining chemical reactivity |
| 01/16/2003 | WO2002029412A3 Selective binding materials |
| 01/16/2003 | WO2002027017A3 Method for quantifying phosphokinase activity on proteins |
| 01/16/2003 | WO2002027016A3 Gene involved in dietary sterol absorption and excretion and uses therefor |
| 01/16/2003 | WO2002026195A3 Oncology tissue microarrays |
| 01/16/2003 | WO2002022862A3 Methods for identifying modulators of protein interactions |
| 01/16/2003 | WO2002022860A3 A system and method for identifying t cell and other epitopes and the like |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002021132A3 Cell assays |
| 01/16/2003 | WO2002020179A3 Modified carbon, silicon and germanium surfaces |
| 01/16/2003 | WO2002018949A3 Capillary array and related methods |
| 01/16/2003 | WO2002018644A3 Mass spectrometric analysis of biopolymers |
| 01/16/2003 | WO2002016946A3 ORAL FLUID RAPID ASSAY FOR HEPATITIS C VIRUS (HCV) ANTIBODIES USING NON-ANTIBODY LABELING OF IgA MOLECULES RECOGNIZING HCV PEPTIDE EPITOPES |
| 01/16/2003 | WO2002016930A3 Computer-based modelling of ligand/receptor structures |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002004657A3 Screening method |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2002002150A8 Stable radioiodine conjugates and methods for their synthesis |
| 01/16/2003 | WO2001098530A3 Interaction of tbx2 and the arf promoter in cell cycle regulator assays |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001086297A3 Methods of identifying the activity of gene products |
| 01/16/2003 | WO2001085941A9 Myc targets |
| 01/16/2003 | WO2001084159A3 Ldl receptor signaling pathways |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001071009A3 Whole-body optical imaging of gene expression and uses thereof |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001068123A9 Monocyte chemoattractant activity of galectin-3 |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 01/16/2003 | WO2001064913A9 Cell cycle proteins associated with rad9, compositions and methods of use |
| 01/16/2003 | WO2001051049A9 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 01/16/2003 | US20030014191 System, method and computer program product for identifying chemical compounds having desired properties |
| 01/16/2003 | US20030013992 Sensor cartridge, sensor feeder, and measuring instrument |
| 01/16/2003 | US20030013954 Tissue sensor |
| 01/16/2003 | US20030013942 Animal health care, well-being and nutrition |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013851 Identification, characterization and three dimensional structure of an active site of interleukin-13 (il-13) |
| 01/16/2003 | US20030013845 Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons |
| 01/16/2003 | US20030013844 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 01/16/2003 | US20030013746 Inhibitor to advance glycosylation endproducts |
| 01/16/2003 | US20030013651 Stimulation of osteogenesis using rank ligand fusion proteins |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013638 P27 prevents cellular migration |
| 01/16/2003 | US20030013637 Novel anti-autoimmune composition by inhibition of GRF action |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013209 Utilization of dexamethasone in the diagnosis of diabetic syndromes; obtain sample, incubate with dexamethsone, monitor cortisol concntration, evaluate for diabetic syndromes |
| 01/16/2003 | US20030013206 Apparatus for use in the detection and analysis of preferential particles in sample |
| 01/16/2003 | US20030013204 Detection of analytes in aqueous environments |
| 01/16/2003 | US20030013203 Microanalysis chip for use in performing high throughput mass spectrometric protein detection |
| 01/16/2003 | US20030013202 Detection of analytes in aqueous environments |
| 01/16/2003 | US20030013198 Taste recognition system and recognition method |
| 01/16/2003 | US20030013184 Device for providing a hybridization chamber, and process unit and system for hybridizing nucleic acid samples, proteins, and tissue sections |
| 01/16/2003 | US20030013176 Enzymatic crystal of preferential protein for use in evaluating inhibitor binding activity |
| 01/16/2003 | US20030013160 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013147 Test system based on microcapillaries |
| 01/16/2003 | US20030013145 Personal breast cancer indicator |
| 01/16/2003 | US20030013144 Detection of modulator of cancer activity; obtain sample containing biopolymers, incubate with modulator, monitor cellular response |
| 01/16/2003 | US20030013143 Methods for identifying vasoprotective agents |
| 01/16/2003 | US20030013142 In vivo protein-protein interaction mapping |
| 01/16/2003 | US20030013141 Process for the discrimination of igg-producing cells from non-igg-producing cells |
| 01/16/2003 | US20030013140 Method of detecting ligand or ligand-like low-molecular weight compound |
| 01/16/2003 | US20030013139 Transgenic cells for use as diagnostic tools in genetic engineering |
| 01/16/2003 | US20030013138 Detection of preferential cell surface proteins; obtain cells, expose to label, detect labelled proteins on cell surface |
| 01/16/2003 | US20030013137 Detection of G protein-coupled receptor activity in cell; obtain cell, incubate with moulator, monitor receptor activity, generate image, determine position of bninding site |
| 01/16/2003 | US20030013136 Detection of modulator of membrane proteins; obtain sample containing membrane protein, incubate with modulators, monitor activity, adjustment in membrane protein activity indicates modulator |
| 01/16/2003 | US20030013135 Spectrum analysis of macromolecules; obtain cell, expose to radio frequency, recover and analyze data |
| 01/16/2003 | US20030013134 Complexing with antibodies |
| 01/16/2003 | US20030013133 Detection of a biological target |
| 01/16/2003 | US20030013132 Non-invasive localization of a light-emitting conjugate in a mammal |
| 01/16/2003 | US20030013131 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 01/16/2003 | US20030013130 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/16/2003 | US20030013129 Method of determining solution concentration and method of examining urine |
| 01/16/2003 | US20030013128 Characterizing nucleic acid and amino acid sequences in silico |
| 01/16/2003 | US20030013127 Detection and determination of the stages of coronary artery disease |
| 01/16/2003 | US20030013126 Detection of preferential polypetide in sample; otain sample containing preferential polyeptide, electrophorese, incubate with probe, detect signal from probe and recover polypeptide |